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The number of new psychoactive substances (NPS) increases rapidly, harming society
and fuelling the need for alternative testing strategies. These should allow the ever-
increasing number of drugs to be tested more effectively for their toxicity and
psychoactive effects. One proposed strategy is to complement rodent models with
zebrafish (Danio rerio) larvae. Yet, our understanding of the toxicokinetics in this
model, owing to the waterborne drug exposure and the distinct physiology of the
fish, is incomplete. We here explore the toxicokinetics and behavioral effects of an
NPS, meta-chlorophenylpiperazine (mCPP), in zebrafish larvae. Uptake kinetics of
mCPP, supported by toxicokinetic modeling, strongly suggested the existence of active
transport processes. Internal distribution showed a dominant accumulation in the eye,
implying that in zebrafish, like in mammals, melanin could serve as a binding site for
basic drugs. We confirmed this by demonstrating significantly lower drug accumulation
in two types of hypo-pigmented fish. Comparison of the elimination kinetics between
mCPP and previously characterized cocaine demonstrated that drug affinities to melanin
in zebrafish vary depending on the structure of the test compound. As expected from
mCPP-elicited responses in rodents and humans, zebrafish larvae displayed hypoactive
behavior. However, significant differences were seen between zebrafish and rodents
with regard to the concentration-dependency of the behavioral response and the
comparability of tissue levels, corroborating the need to consider the organism-internal
distribution of the chemical to allow appropriate dose modeling while evaluating effects
and concordance between zebrafish and mammals. Our results highlight commonalities
and differences of mammalian versus the fish model in need of further exploration.
Keywords: meta-chlorophenylpiperazine (mCPP), cocaine, psychoactive drugs, toxicokinetics, toxicity, behavior,
melanin
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INTRODUCTION
The production and consumption of synthetic drugs of abuse,
also known as NPSs, have been increasing rapidly (Goosdeel,
2016), intensifying the need for an efficient assessment of
their toxicity and behavioral effects. Zebrafish (Danio rerio)
larvae have been suggested as an alternative to rodent models
because, opposite to rodents, drug testing can be achieved with
high information content at medium to high throughput. Yet,
understanding of the chemical fate in zebrafish larvae is far from
complete (Rihel and Ghosh, 2014). In our previous study we
found that, upon waterborne exposure, cocaine accumulation
was three-fold higher in zebrafish larval eye than in the brain or
trunk (Kirla et al., 2016). This finding sheds light on potential
binding sites of chemicals in zebrafish larvae. Cocaine, being a
basic drug, is known to bind to melanin in human and rat hair
(Nakahara et al., 1992; Cone et al., 1993; Joseph et al., 1997).
Since zebrafish larvae are highly pigmented, especially in the eyes,
binding to melanin could be a very important mechanism for the
accumulation of basic drugs in this species. We hypothesized that
in zebrafish larvae melanin plays a role in binding basic drugs,
with affinities potentially differing depending on the chemical
structure, as has been shown with synthetic melanin (Baweja
et al., 1977).
To investigate this hypothesis, we chose the NPS mCPP, also
a basic drug with psychoactive properties (Arbo et al., 2012)
but structurally different from cocaine in having a piperazine
ring. mCPP is an N-substituted piperazine with a molecular
weight of 196.68 g/mol, an octanol-water partition coefficient
(logP) of 2.06 and a pKa of 8.87. This chemical met our two
selection criteria: Firstly, it is known to bind to melanin, at least
in mammalian hair (Gaillard et al., 2013), but with presumably
lower affinity than cocaine. The latter characteristic has not yet
been directly shown with mCPP, but it is known for fluphenazine,
an anti-psychotic therapeutic drug with a piperazine ring (Baweja
et al., 1977; Tardy et al., 2014). Secondly, mCPP is a widely
used synthetic drug of abuse, and we were interested in
assessing its toxicity and behavioral effects in zebrafish larvae
in order to compare them with mammals. In rodents, mCPP
was shown to lead to reduced locomotion (Klodzinska et al.,
1989; Lucki et al., 1989), and in humans is known to reduce
psychomotor activity (Murphy et al., 1989; Broocks et al., 1997;
Sabbe et al., 2001). In mammals, mCPP, i.e., the active drug,
is known to be eliminated by phase-I oxidation and phase-II
glucuronidation and sulfation (Mayol et al., 1994; Rotzinger et al.,
1998).
Thus, using mCPP as an example, we here explore and
discuss the (a) importance of melanin as an internal binding
Abbreviations: dpf, days post fertilization; hpf, hours post fertilization;
IEC50, internal effective concentration; ILC50, internal lethal concentration;
INTC, maximum internal non-toxic concentration; LC-MS/MS, liquid
chromatography coupled to tandem mass spectrometry; MALDI MSI, matrix
assisted laser desorption ionization mass spectrometry imaging; mCPP, meta-
chlorophenylpiperazine; MNTC, maximum non-toxic concentration; MRM,
multiple reaction monitoring; NPS, new psychoactive substances; OCTs, organic
cation transporters; OECD, Organisation for Economic Co-operation and
Development; PTU, phenylthiourea; SULTs, sulfotransferases; WT, wild-type;
zFET test, zebrafish embryo toxicity test.
site of basic drugs in zebrafish larvae and (b) the need to
consider kinetics and tissue distribution of psychoactive drugs
to allow appropriate tissue dose modeling for interpretation of
toxicity and behavior and for assessment of concordance between
zebrafish and mammals.
MATERIALS AND METHODS
Animal Husbandry and Ethics
Zebrafish (Danio rerio) of OBI strain were maintained in a flow-
through system (Müller & Pfleger, Rockenhausen, Germany) at
28◦C under a 14-h light/10-h dark cycle according to published
guidelines (Nuesslein-Volhard and Dahm, 2002). Fish were fed
twice daily a diet of live-hatched brine shrimp (Artemia nauplia)
and flake fish food (Tetramin, Switzerland). Breeding was carried
out by group crosses. Eggs were collected in the morning
and raised in an incubator at 28◦C with the same light/dark
cycle as adults in reconstituted water [294.0 mg/l CaCl2.2H2O,
123.2 mg/l MgSO4.7H2O, 64.74 mg/l NaHCO3 and 5.7 mg/l KCl;
ISO 15088:2007(E), 2007] in Petri dishes of 50–60 embryos per
dish. All experimental procedures were performed in accordance
with the animal protection guidelines and the experiments with
the larvae were approved by the Swiss Cantonal Veterinary
Office.
Zebrafish Embryo Toxicity Test (zFET)
The mCPP was purchased from Lipomed, Switzerland (>98.5%
pure) with special permission from the Swiss Federal Office
for Public Health to use controlled substances and treated
according to the institutional safety procedures. In order to
determine the toxic and non-toxic concentrations of mCPP, the
zFET test was performed as recommended in the guidelines
of the Fish Embryo Toxicity Test, OECD, Test Guideline
236. Briefly, zebrafish embryos at two to four cell-stages
were distributed one embryo per well in a 24-well plastic
microtiter plate (Huber, Switzerland) and exposed to mCPP (10
embryos/concentration). Exposure concentrations were chosen
based on initial range-finding tests, and included 0.01, 0.05, 0.1,
0.5, 1, 2.5, 5, 50, and 100 µM. Final exposure concentrations
were achieved by dissolving 1 mM stock solution of mCPP
in an appropriate volume of reconstituted water medium. Test
solutions were exchanged with freshly prepared solutions daily.
The embryos were monitored from 24 to 120 hpf and sub-
lethal and lethal outcomes were noted in µM. Lethal and sub-
lethal concentrations were calculated using the four-parameter
sigmoidal dose-response (variable slope) model in GraphPad
Prism R© 6.
Toxicokinetics of mCPP
Uptake, Biotransformation and Elimination of mCPP
All exposures for toxicokinetic analyses were done with 5 dpf
larvae in a 48-well plastic plate (Huber, Switzerland) at 28◦C.
For the uptake analysis, 16 larvae were incubated, one larvae per
well, in 5 µM mCPP and were collected after 0.25, 1, 3, 6, 8, and
10 h exposure into pre-weighed 2 ml lysing matrix tubes with
metal beads (MP Biomedicals, France). Samples were washed
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with phosphate buffered saline, snap frozen in liquid nitrogen
and stored at−80◦C until analysis. For elimination experiments,
following 8 h of uptake, larvae were transferred into reconstituted
water (drug-free medium) and sampled at 1, 3, 6, 18, 24, 27, and
48 h of depuration. As the lysing matrix tubes contained beads,
making it difficult to aspirate all liquid medium, wet weights of
5–7 dpf larvae were instead measured in a separate experiment
using 1.5 ml Eppendorf tubes, where liquid medium was gently
aspirated before weighing. Larvae measured over 5–7 dpf gave an
average weight of 360 ± 16 µg and therefore, 360 µg was used
to calculate internal body concentrations (Supplementary Table
S2A).
To analyze the kinetics of uptake and elimination, frozen
samples were defrosted first at 4◦C for 1 h and then at room
temperature for about 2 h. Samples were homogenized by adding
ammonium formate buffer (500 µL, 5 µM, pH 3.1) and using
a Fast prep R©- 24 Instrument (MP, Biomedicals, France). To
the homogenate, internal standard (mCPP-D3) was spiked at a
concentration of 5 µM. Extraction was carried out with 500 µL
acetonitrile (Sigma Aldrich, Switzerland) and samples were
centrifuged at 10,000 rpm for 5 min. Supernatant was collected
into a fresh tube, mixed with eluent buffer (10 mM ammonium
formate with 0.1% formic acid and acetonitrile with 0.1 % formic
acid) and were injected into the LC-MS/MS (Applied Biosystems
5500 triple QTRAP, AB Sciex, Germany) for the analysis of mCPP
and metabolites. MRM transitions were acquired for mCPP (197
→ 154.1), OH-mCPP (213→ 134) and OH-mCPP glucuronide
(389→ 213).
Distribution of mCPP in Zebrafish Larvae
Qualitative analysis by MALDI MSI
Spatial distribution of mCPP in zebrafish larvae was studied
using MALDI MSI according to the protocol described in Kirla
et al. (2016). Briefly, larvae were exposed to 5 µM mCPP
in a similar way as for the uptake analysis. After 8 h of
uptake, larvae were euthanized and frozen in Optimal Cutting
Temperature media (Thermo ScientificTM, United States) on dry
ice. Individual blocks were mounted onto the cryotome (Microm
HM 560, Thermo ScientificTM, United States) and 16 µm-thick
coronal, sagittal and transverse sections were made. Sections
were collected on the indium tin oxide coated glass slides and
immediately dried under vacuum to avoid any redistribution of
the drug. MALDI matrix (10 mg/ml of 2,5-dihydroxybenzoic
acid; 0.1% TFA/ACN 1:1) was applied on the samples and
images were acquired on a Flashquant Workstation (AB Sciex,
Germany) in positive ion mode. Images were processed using
Tissue view software (AB Sciex, v1.1) and overlaid with the
optical images.
Quantitative analysis by LC-MS/MS
To quantitate mCPP in different tissues, larval brain, eyes
and trunk were dissected out as described in (Turner et al.,
2014). Brains, eyes and trunks from 16 fish were pooled into
different tubes and analyzed using LC-MS/MS with the method
described in (Kirla et al., 2016). Wet weights of the dissected
brain, eyes and trunk were measured individually before freezing
(Supplementary Table S2B).
Hypo-Pigmented Fish Experiments
Albinos (slc45a2) were obtained from the facility of Stephan
Neuhauss from the University of Zurich and were raised in our
facility as described above for the WT zebrafish. To produce
hypo-pigmented fish chemically, zebrafish embryos were exposed
to 200 µm of PTU by dissolving in appropriate volume of embryo
medium at 22 hpf when melanin synthesis begins (Kimmel et al.,
1995). Solutions were exchanged every day until 5 dpf. Albinos
and PTU-treated larvae of 5 dpf were exposed to 5µM mCPP, and
its concentration after 8 h of uptake was measured in the whole-
body homogenates and in the dissected tissues by LC-MS/MS as
described above.
Toxicokinetic Modeling
Toxicokinetic modeling was performed as described in Kirla et al.
(2016). Briefly, one-compartment and multi-compartment (i.e.,
two compartment) models were applied to determine empirical
rates of uptake and elimination for mCPP. The one-compartment
concept (fitted one-compartment model 1) can be described by
the following equation (Stadnicka et al., 2012):
d
dt
Cint(t) = kin · Cw(t)− kout · Cint(t) (1)
where Cint(t) is the internal chemical concentration (mg kg−1),
Cw(t) is the chemical concentration in the water (mg L−1), kin is
the uptake rate constant (L kg−1 h−1)and kout is the elimination
rate constant (h−1). Fitted one-compartment model 1 and
measured internal concentrations of mCPP were compared with
predicted values obtained by applying a simple one-compartment
toxicokinetic model which assumes uptake and elimination of
organic chemicals as a function of the octanol-water partition
coefficient, as well as the lipid content, weight and trophic level of
the species (Hendriks et al., 2001) (predicted one-compartment
model 2). This model can also be described by the equation
1; however, here the uptake and elimination rate constants
were not fitted but determined based on the physico-chemical
properties of mCPP and larvae characteristics as described in
Hendriks et al. (2001). All the parameters and equations used
for the determination of uptake and elimination rate constants
in predicted one-compartment model 2 are presented in the
Supplementary Table S1 (equations S1–S5).
A multi-compartment model (fitted multi-compartment
model 3) was applied as described in detail in (Kirla et al., 2016),
in order to account for the mCPP distribution in the larvae. In
this model, eyes are distinguished as a separate compartment due
to uptake and elimination processes different than for the rest of
the body. Therefore, different rate constants can be determined
for the eyes and for the rest of the body:
d
dt
Cint_eyes(t) = kin_eyes · Cw(t)− kout_eyes · Cint_eyes(t) (2)
d
dt
Cint_rest(t) = kin_rest · Cw(t)− kout_rest · Cint_rest(t) (3)
where Cint_eyes(t) is the chemical concentration in the larvae’s
eyes (mg kg−1), Cint_rest(t) is the chemical concentration in the
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larvae’s tissues and organs other than eyes (mg kg−1), Cw(t) is
the chemical concentration in the water (mg L−1); kin_eyes and
kin_rest are the uptake rate constants (L kg−1 h−1) and kout_eyes
and kout_rest are the elimination rate constants (h−1) in the eyes
and in the rest of the body, respectively.
The relationship between chemical concentrations in eyes and
in the whole fish was determined over time by the following
equation:
Cint_larvae(t) =
Cint_eyes(t) ·Weyes + Cint_rest(t) · Wrest
Weyes +Wrest (4)
where Cint_larvae(t) is the chemical concentration in the whole
larvae (mg kg−1), Weyes is the weight of eyes (kg) and Wrest is the
weight of larvae’s tissues and organs other than eyes (kg). Larvae’s
weight is the sum of Weyes and Wrest.
All models were implemented and solved using ModelMaker
(version 4.0, Cherwell Scientific Ltd., Oxford, United Kingdom)
with the settings described in the Supporting Information (SI –
page 9).
Monitoring of Locomotory Behavior
Behavioral testing was performed on 5 dpf larvae. Larvae were
distributed one per well in a 48-well plate with embryo medium
(500 µL) and incubated for 3–4 h for acclimatization in the
housing incubator. After acclimatization, larvae were exposed
according to one of the two different mCPP concentration
setups: setup 1, low concentrations – 0.01, 0.05, 0.25, 0.5,
and 1 nM and setup 2, high concentrations – 0.001, 0.01,
1, 2.5, and 5 µM. Untreated larvae served as controls in
each of the experiments. Drug challenge was conducted
on three different plates on independent days with n = 8
larvae/concentration or untreated controls/plate. Movement
of each larva was monitored using the ZebraBoxTM video
tracking system (View Point Life Sciences, Version 3, Lyon,
France) with a camera frame rate of 25 frames per second. In the
software user interface, distance traveled was categorized
into three types of movements: low speed movements
(<2 mm/s), medium speed movements (2–10 mm/s) and
high speed movements (>10 mm/s). The average distance
traveled was then calculated from the different speed
movements.
Following testing behavior on instant drug exposure, each
plate was immediately placed on the recording platform and
each individual animal was tracked for 70 min with alternating
dark and light phases every 10 min. For recording behavior after
extended drug exposure, a different set of fish were exposed
to mCPP in another plate and placed in the incubator for
8 h before measuring the locomotor activity using the same
protocol as for immediate drug exposure. Data was exported
to and analyzed in Microsoft Excel 2010 and the graphs were
plotted in GraphPad Prism R© (Version 6 for Windows, CA,
United States).
Statistical Analysis
All graphs were plotted using GraphPad Prism R© (Version
6). Statistical analysis for the behavior data was performed
using RStudio (Version 0.98.1103) by repeated measures
Analysis Of Variance (ANOVA) as described in Kirla et al.
(2016). Briefly, data were analyzed in three steps: first, data
were assessed for the significance of independent factors,
i.e., time, concentration and plate with the dependent factor
being the locomotor activity. Next, data were segregated
based on the light and dark conditions (considering from
the first light condition that followed dark period) and
ANOVA was performed. Finally, at each lighting condition,
ANOVA was performed comparing each concentration to
control to test if there is a significant effect followed by
Bonferroni’s post hoc analysis. Statistical significance was set at
α = 0.003.
RESULTS
mCPP Uptake, Biotransformation and
Elimination in Zebrafish Larvae
To quantify the kinetics of mCPP uptake, zebrafish larvae
were exposed to 5 µM (0.98 mg/L) mCPP and the internal
concentrations were quantified over time. The 5 µM mCPP
concentration was the highest one not affecting the larvae
phenotype when exposed at 4 dpf for 24 h (Supplementary
Figure S1A). mCPP was detected in the whole-body homogenates
already at the earliest assessed time point (15 min) and the uptake
increased gradually, reaching measured internal concentrations
of 308 ± 18 mg/kg within the 8 h of exposure (Figure 1).
Based on the fitted one-compartment model 1 (see Equation
1: Materials and Methods – Toxicokinetic modeling), the
uptake rate constant, kin, was determined to be 112.9 ± 7.4 L
kg−1 h−1.
To follow the elimination of mCPP over time, zebrafish larvae
were transferred into clean water after 8 h of uptake. Based on
the measured data, the half-lives could be distinguished into
two values: an initial half-life of 4.5 h during the first 6 h of
the elimination phase followed by a longer half-life of 28.5 h
during the rest of the duration (Figure 1 and Supplementary
Figure S2). About 13% (i.e., 40 mg/kg) remained after 48 h of
elimination with an overall elimination rate constant, kout, of
0.25 ± 0.03 h−1 as derived from the fitted one-compartment
model.
Zebrafish larvae biotransformed mCPP by oxidation
to OH-mCPP, followed by conjugation to a glucuronide
(Supplementary Table S3). About 1–2% of the parent compound
taken up underwent oxidation and glucuronidation over
the same time span as analyzed for the uptake kinetics,
i.e., 8 h.
The predicted one-compartment toxicokinetic model
(Materials and Methods – Toxicokinetic modeling, model 2)
(Kirla et al., 2016), which assumes passive uptake and elimination
of mCPP based on its octanol-water partition coefficient (log
P = 2.06), predicted much lower whole-body concentrations
than those actually measured (Figure 1). Correcting the logP
value based on the pKa and pH (log D = 0.91), would result in
the predicted internal concentrations much lower than those
presented in Figure 1.
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FIGURE 1 | Uptake and elimination kinetics of mCPP in zebrafish larvae. Larvae (16 per treatment) at 5 dpf were exposed to 5 µM mCPP for 8 h and thereafter
placed in clean medium for up to 48 h. A set of untreated larvae served as control. At different time points during the uptake and elimination phase, mCPP
concentrations in the whole-body homogenates were measured by LC-MS/MS. Filled circles show data from two independent experimental replicates focusing on
uptake kinetics; open circles show data from two additional independent experimental replicates focusing on both uptake and elimination kinetics. Dashed line in
blue shows the fitted one-compartment model 1; solid line in red shows the prediction of uptake and elimination based on one-compartment toxicokinetic model 2;
solid line in blue shows the fitted multi-compartment toxicokinetic model 3.
mCPP Binding in Zebrafish Eye Is
Reversible
To visualize the distribution pattern of mCPP in the larvae of
zebrafish after exposure to 5 µM mCPP for 8 h, we used MALDI-
MSI to analyze coronal, sagittal and transverse sections. Coronal
sections revealed mCPP accumulation with high intensity in the
head region and with lesser intensity in the trunk (Supplementary
Figures S3A,B). Sagittal sections showed mCPP signal in the brain
and eye (Supplementary Figures S3C,D). Transverse sections
made through forebrain, midbrain and hindbrain confirmed the
presence of mCPP in the brain (Supplementary Figures S3E–J).
Sagittal sections of unexposed control fish showed no mCPP
signal (Supplementary Figures S3K,L).
To quantify the distribution of mCPP in the larvae after
an exposure for 8 h to 5 µM mCPP, brain, eyes, and trunk
were dissected and mCPP was quantified by LC-MS/MS. The
by far highest concentration of mCPP was found in the eyes
(1694 ± 76 mg/kg) followed by the brain (263 ± 11 mg/kg) and
the trunk (143± 5 mg/kg) (Figure 2A).
Due to the high accumulation of mCPP in the eyes, one-
compartment approaches could not describe the data well
(Figure 1). Therefore, a multi-compartment toxicokinetic model
was applied as described in (Kirla et al., 2016) in order to
distinguish eye as a separate compartment from the rest of the
body (Supplementary Figure S4). Modeling results demonstrate
that, while the distribution in the brain and trunk is about 20-fold
higher than predicted by the simple partitioning assumption, the
distribution in the eye compartment is over 250-fold higher than
predicted. The kin derived from the multi-compartment model
in the eyes (i.e., kin_eyes, Equation 2) was 325 ± 5.9 L kg−1 h−1
and 143.2 ± 50 L kg−1 h−1 in the rest of the body (i.e., kin_rest,
Equation 3).
Measuring the mCPP levels in the dissected brain, trunk and
eyes after 48 h in clean water revealed significant elimination
from all tissues examined. Of the initial concentrations
accumulated in the different tissues after 8 h of uptake, 4.5%
(11.9 ± 3.9 mg/kg) remained in the brain, 5% (7.3 ± 2.6 mg/kg)
in the trunk and 8% (134.5 ± 16 mg/kg) in the eyes, with
the latter compartment still showing significantly higher mCPP
concentrations compared to the two former ones (Figure 2B).
Here, the kout in the rest of the body excluding eyes was
0.8 ± 0.3 h−1, while it was much slower in the eyes with a rate
constant of 0.05 ± 0.003 h−1. The fitted multi-compartment
model gave half-lives of 13 h and 48 min for the elimination from
the eyes and the rest of the body, respectively.
Hypo-Pigmented Fish Accumulate Much
Less mCPP Than Wild-Type Fish
To test our hypothesis of melanin serving as a binding site
involved in drug accumulation, we used two types of hypo-
pigmented fish: albinos (slc45a2) (Tsetskhladze et al., 2012) and
PTU treated fish. For the latter, zebrafish embryos at 22 hpf
were exposed to 200 µM PTU, a standard treatment used to
prevent pigmentation of the embryos (Karlsson et al., 2001; R,
2002). mCPP levels in the whole-body homogenates, as well
as in dissected brain, trunk and eyes, were compared between
the WT, albinos and PTU-treated fish after 8 h of exposure to
5 µM mCPP. Whole-body concentrations of mCPP were about
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FIGURE 2 | mCPP concentrations in dissected tissues quantified by LC-MS/MS. Zebrafish larval brain, eyes, and trunk were dissected from 16 larvae after being
exposed to 5 µM mCPP or unexposed as controls either for 8 h (A) or for 8 h followed by 48 h of elimination (B) and analyzed for mCPP. Values are reported as
original data with each data point representing the information obtained from a pool of 16 larval tissues in one of three independent experiments. Horizontal lines
represent the mean of the experimental replicates. One-way ANOVA followed by Tukey’s multiple comparison test revealed a significant difference for brain versus
eyes and trunk versus eyes (∗∗∗p < 0.0001) for both sampling time points (A,B).
7 times lower in the albinos (36 mg/kg) and 5 times lower in
the PTU-treated fish (49 mg/kg) compared with the WT larvae
(250 mg/kg) (Figure 3A). mCPP concentrations in the dissected
tissues from hypo-pigmented fish were about 10 times lower in
the brain (Figure 3B), 20 times lower in the trunk (Figure 3C)
and 50 times lower in the eyes (Figure 3D) compared to the
concentrations in the tissues of WT fish.
mCPP Causes Hypoactivity in Zebrafish
Larvae
We determined the effects of mCPP on the locomotory behavior
of 5 dpf WT zebrafish larvae. Zebrafish larvae were exposed to
different concentrations of mCPP and locomotor activity was
measured either immediately after the exposure start (Figure 4A)
or after 8 h of exposure (Figure 4B). At both time points,
locomotor activity of mCPP-exposed larvae was lower compared
to the untreated (mCPP-free) controls (Figure 4, Supplementary
Table S4, and Supplementary Figures S5, S6), with the effect
being significant at concentrations ≥ 0.001 µM. However, there
was no apparent concentration-dependency in the hypoactive
behavior.
DISCUSSION
This study aimed to advance knowledge on the suitability
of zebrafish larvae as a vertebrate model to rapidly evaluate
the toxicokinetics, toxicity and behavioral effects of classical
and NPSs. As previously observed for cocaine (Kirla et al.,
2016), mCPP is rapidly taken up by the larvae and dominantly
accumulates in the eye. Using hypo-pigmented fish, we
demonstrate that the accumulation in the eye compartment
is mediated by melanin. Zebrafish larvae respond to mCPP
with reduced activity as rodents and humans; however, whether
the mechanisms leading to this behavior are similar requires
further investigation. Significant differences were seen between
zebrafish and rodents with regard to the concentration-
dependency of the behavioral response and the comparability
of tissue levels, corroborating the need to consider tissue-
specific chemical distribution to allow appropriate dose modeling
while evaluating effects and concordance between zebrafish
and mammals. Our results thus highlight commonalities and
differences of mammalian versus the fish model that need further
exploration.
Melanin Is an Important Binding Site for
Basic Drugs in Zebrafish Larvae
Our study demonstrates that melanin acts as an important
binding site for basic drugs in zebrafish larvae, with the eye
being the dominant accumulation compartment. We previously
hypothesized the role of melanin in cocaine binding (Kirla et al.,
2016); here we provide experimental proof for this hypothesis
by studying mCPP distribution in hypo-pigmented zebrafish
larvae versus WT fish. In our previous study, we observed
that cocaine accumulation in the eye played no role in the
behavioral effects analyzed (Kirla et al., 2016). Therefore, it is
unlikely that mCPP accumulation in the larval eye measured
in this study played any role in the hypoactivity seen. We
conducted another study to evaluate the effect of accumulated
cocaine on the zebrafish larval eye by electroretinography,
which revealed that cocaine accumulation in the retina does
not adversely affect outer retina function. It leads, however, to
increased light sensitivity, a finding requiring further exploration
to explain the mechanisms underlying this effect (Niklaus et al.,
2017). The role of pigmentation in drug accumulation has
been originally demonstrated in rabbits and hamsters where
phenothiazines accumulated in the eyes of WT but not of
albino animals (Potts, 1962). Later, binding to synthetic melanin
or to hair was also shown for other aromatic compounds,
such as chloroquine and cocaine (Potts, 1964; Larsson and
Tjalve, 1979; Borges et al., 2003). All these compounds are
basic drugs. Three striking features of melanin are thought
to contribute to its ability to bind basic drugs: first, its high
number of carboxylic acid residues which, with their negative
charge, can lead to ionic interactions with a protonated nitrogen
in the binding drug [Figure 5-(a1)] (Larsson, 1993; Karlsson
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FIGURE 3 | mCPP concentrations quantified by LC-MS/MS in the whole-body homogenates and dissected tissues of wild type and hypo-pigmented fish. Wild-type,
albino and PTU-treated fish at 5 dpf (16 larvae per treatment) were either exposed to 5 µM mCPP or unexposed as controls for 8 h and mCPP was quantified in
larval whole-body homogenates (A) or in dissected brain (B), trunk (C), and eyes (D). Values are reported as original data with each data point representing the
information obtained from a pool of 16 larval tissues in one of the two or three independent experiments. Horizontal lines represent the mean of the experimental
replicates. One-way ANOVA followed by Tukey’s multiple comparison test revealed significant difference between albino versus wild-type and PTU versus wild-type
fish both for whole-body homogenates and all dissected tissues (∗∗∗p < 0.0001).
and Lindquist, 2016); second, its great number of aromatic
rings, which can contribute to interactions with the pi bonds
of the binding drug [Figure 5-(b1)] (Reilly et al., 2015); and
third, its electron accepting and donating properties, which
can be involved in charge-transfer reactions with an electron
donating or accepting substance [Figure 5-(c)] (Mason, 1977).
Other mechanisms, such as hydrogen bonding [Figure 5-(d)]
and van der Waal’s interactions, can be suggested as a fourth
type of interaction (Mason, 1977; Karlsson and Lindquist, 2013,
2016).
We here show that basic drug binding by melanin is a
phenomenon occurring also in the zebrafish eye. Furthermore,
we demonstrate that the strength of binding varies depending
on the physico-chemical properties of the drug (Zane et al.,
1990) and the type of bonding (Mason, 1977; Tjälve et al., 1981).
Accumulation of mCPP in the eye is much more reversible
than that of cocaine: after 48 h of elimination, only 8% of the
maximum accumulated mCPP amount persisted in the eyes,
compared to 87% for cocaine, as observed in our previous study
(Kirla et al., 2016). Referring to the four mechanisms listed
above, we suggest several important structural differences that
may contribute to stronger interactions of melanin with cocaine
compared to mCPP (Figure 5). First, cocaine has one more
site available for ionic interaction between the carboxylic acid
residues in cocaine [Figure 5-(a2)] and a protonated nitrogen
in melanin. Then, while both cocaine and mCPP have an
aromatic ring for pi interactions with melanin [Figure 5-(b1)],
cocaine contains two more pi bonds than mCPP [Figure 5-
(b2)]. Furthermore, cocaine, with its oxygen atoms [Figure 5-
(c)], can interact with melanin via charge transfer (Powell et al.,
2007), while for mCPP this mechanism does not seem possible.
Cocaine, moreover, has three more opportunities for hydrogen
bridging with the donor melanin, i.e., cocaine can accept five
hydrogen bonds (represented by asterisk) (CID=446220 National
Center for Biotechnology Information, 2017) while mCPP can
accept only two [Figure 5-(d)] (CID=1355 National Center
for Biotechnology Information, 2017). Taken together, these
mechanisms plausibly explain why the binding of cocaine to
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FIGURE 4 | Effect of mCPP on the locomotor activity of zebrafish larvae. Larvae of 5 dpf were exposed to different concentrations of mCPP and tracked either
immediately (A) or after 8 h of exposure (B). Distance traveled by the fish was analyzed every 2 min for 70 min with dark (black bars on X-axis) and light phases
alternating every 10 min. Data were assessed using repeated measures ANOVA. Values are reported as mean ± SEM from 3 independent experiments (n = 8
larvae/concentration or control/experiment).
melanin is stronger, resulting in cocaine’s much slower release
from the eye compared to mCPP. Relating these structural
properties to the affinity of binding to melanin should aid in the
prediction of basic drug binding to melanin and retention in the
zebrafish eye.
mCPP Is More Acutely Toxic Than
Cocaine
Cocaine and mCPP also differ in their uptake kinetics
and toxicity. The uptake rate constant, kin, for mCPP
(112.9 L kg−1 h−1) is 10 times higher than for cocaine
(12.9 L kg−1 h−1) (Kirla et al., 2016). Because of the faster
uptake, the 5 µM exposure concentration of mCPP resulted
in internal whole-body and tissue concentrations almost equal
to those occurring after exposure to 50 µM of cocaine.
Based on comparing model predictions for passive uptake
and experimental data, we already suggested active uptake
mechanisms for cocaine (Kirla et al., 2016). For mCPP, they
are apparently even more important. This difference cannot
be explained by the simplicity of the applied model. While
increasing the model complexity generally improves model
performance (Rowland et al., 2017), and more sophisticated
Physiologically Based Toxicokinetic (PBTK) models have already
been developed for adult stages of zebrafish (Péry et al.,
2014; Brinkmann et al., 2016), no approach has, as of yet,
been proposed for fish larval stages, for which chemical
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FIGURE 5 | Schematic representation of possible binding sites of melanin with mCPP and cocaine. Box 1 and box 2 are selected sites of melanin proposed to be
important for the interactions with chemicals. (a1) an example of an ionic interaction between a carboxylic acid and a protonated nitrogen (solid line) between
melanin and cocaine/mCPP; (a2) additional ionic interaction site in cocaine with a carboxylic acid group; (b1) interactions between aromatic rings of melanin and
cocaine/mCPP (solid line); (b2) an example of a double bond site in cocaine for the interaction with aromatic rings of melanin; (c) an example of a charge-transfer
reaction site (oxygen) possible only in cocaine; (d) an example of hydrogen bridging site with five hydrogen acceptor sites in cocaine and only two in mCPP (indicated
by asterisk). For example, Eumelanin structure has been adapted and modified from Karlsson and Lindquist (2016).
internal distribution differs. It has, however, been shown that
the one-compartment model applied here is in agreement
with the PBTK models regarding the prediction of chemical
concentrations in whole fish (Stadnicka et al., 2012). Finally, the
difference in uptake of mCPP and cocaine is also corroborated
when comparing measured (logBCF = 2.65) and predicted
bioconcentration factors (logBCF = 0.925; regression based
method by the US Environmental Protection Agency’s EPISuite
programTM) (EPISuiteTM; US EPA, 2017). For cocaine, it has
been demonstrated that the uptake across the blood-brain barrier
is carried out by a proton-antiporter (Chapy et al., 2014). To our
knowledge, the type of active transporters for mCPP is not yet
known. Based on a previous study, we can, however, propose
a possible mechanism: OCTs, which have been shown to be
involved in the active uptake of imatinib, another piperazine
drug, in human cells (Thomas et al., 2004). The fact that mCPP is
present as a cation under physiological pH supports this proposal.
The expression and function of OCTs has been previously
demonstrated in zebrafish in tissues such as heart, kidney, brain,
eye and liver (Mihaljevic et al., 2016). Therefore, the higher
uptake of mCPP compared to cocaine may be explained by
the fact that the type of transporters involved for mCPP are
more prominent. This proposal opens up avenues for future
investigations on the molecular mechanisms of mCPP uptake.
Compared to cocaine (Kirla et al., 2016), mCPP showed higher
toxicity in short-term 24 h exposure at 4 dpf (Supplementary
Figure S1A). From this data, the INTC, i.e., the concentration
at which no significant effects were seen for mCPP, was
estimated to be almost 7 fold lower (2.25 mmol/kg) compared
to cocaine (14.65 mmol/kg) (Supplementary Information –
equation S6). To assess the developmental effects of mCPP,
zebrafish embryos were exposed from 0-5 dpf (Supplementary
Figure S1B). The internal lethal and sub-lethal concentrations
were estimated and compared to the acute toxicity of cocaine
(Supplementary Information – equation S7). The ILC50 of
mCPP is six-fold lower (51.75 mmol/kg) than that for cocaine
(316.7 mmol/kg) and IEC50 is 50 times lower (0.47 mmol/kg)
than for cocaine (25.1 mmol/kg). The sub-lethal effects
noted upon mCPP exposure, such as heart oedema and
yolk sac oedema, were more severe compared to cocaine.
Furthermore, other effects such as protruded mouth and bent
body axis were observed only on exposure to mCPP. These
results suggest that mCPP not only can elicit developmental
effects, a mode of action that has never been investigated
in mammals, but that, moreover, different mechanisms may
be involved in the developmental toxicity of cocaine and
mCPP.
Toxicokinetics and Behavioral Effects of
mCPP in Zebrafish Larvae: Evaluation of
Concordance and Discordance to
Mammals
Although zebrafish larvae and mammalian models differ in
the exposure routes for chemicals, the kinetics and behavioral
effects can be compared based on internal concentrations. When
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comparing the uptake rate constant, kin (L kg−1 h−1), from
the exposure medium into the larvae with the absorption rate
constant, ka (h−1), from plasma in humans, the kin of mCPP in
zebrafish larvae (112.9) was almost 40 times higher than the ka
in humans (2.79) upon oral administration (Feuchtl et al., 2004).
One possible explanation for the high uptake rate in zebrafish
larvae versus humans could be that, in terms of the barriers to
drug absorption present in these species, the intestinal barrier
in humans may be stronger than the skin barrier or the gills in
zebrafish larvae. However, since gill lamellae in zebrafish larvae
become completely functional only from 12 to 14 dpf, the major
barrier at this stage would be skin (Rombough, 2002). The active
transport mechanisms could further contribute to higher uptake
in zebrafish larvae.
Biotransformation of mCPP in zebrafish larvae is concordant
to oxidation (phase I) and glucuronidation (phase II) in
mammals (Mayol et al., 1994; Rotzinger et al., 1998). mCPP
biotransformation in rodents is known to also lead to phase II
sulfation (Mayol et al., 1994), but no sulfate conjugates were
observed in zebrafish larvae. Although the expression of several
SULTs has been characterized at this developmental stage in
zebrafish, the physiological relevance of their expression is not
yet clear and needs further investigation (Yasuda et al., 2008;
Mohammed et al., 2012). Thus, it is not yet known if the SULT
responsible for the biotransformation of mCPP is active in 5 dpf
zebrafish larvae.
The initial 4.5 h elimination half-life (t1/2) of mCPP in
zebrafish larvae shows concordance to the t1/2 of 4 h in humans
(Feuchtl et al., 2004), which is striking given the differences
in the size and routes of elimination, i.e., whole-body in the
larvae vs. plasma in humans. This could be explained by
the fact that different half-lives were obtained in the eyes
(t1/2 = 13 h) and the rest of the body (t1/2 = 48 min).
Therefore, because of the accumulation of mCPP in the eyes,
the multi-compartment model best fits the toxicokinetics of
mCPP.
Zebrafish larvae, tested over a wide concentration-range
(0.00001–5 µM mCPP), respond consistently with significant
hypoactive behavior at 0.01 µM or above, but the behavioral
effect does not show concentration-dependency. In rodents,
mCPP also leads to decreased locomotor activity, but in a
dose-dependent manner when administered via intraperitoneal
or sub-cutaneous injection (Klodzinska et al., 1989; Lucki
et al., 1989; Gleason et al., 2001). mCPP is known to interact
with different serotonin (5-HT) receptors and modulate the
release of serotonin. In rodents, the hypoactivity has been
demonstrated to occur through activating 5-HTC receptors
(Klodzinska et al., 1989; Gleason et al., 2001). Zebrafish larvae
have a serotonergic neurotransmission system highly similar
to mammals (Brustein et al., 2003; McLean and Fetcho, 2004;
Panula et al., 2006, 2010). Therefore, the hypoactive behavior
observed in zebrafish larvae could also be due to alterations in
the serotonin neurotransmission. A 5 µM mCPP (≈1.4 mg/kg
external concentration) exposure to zebrafish larvae resulted
in a brain concentration of 0.3 ng/µg after 8 h exposure. In
rodents, a 10 times lower brain concentration (0.02 ng/µg) was
achieved 1 h post-injecting 10 mg/kg mCPP (Fuller et al., 1981)
which led to hypoactive behavior (Gleason et al., 2001). The
reason for the higher brain concentrations in zebrafish larvae
compared to rodents could be the incomplete development of the
blood-brain barrier at this stage (Jeong et al., 2008). Yet, if we
assume linear uptake of mCPP across the tested concentration
range that resulted consistently in significant hypoactivity in
zebrafish larvae (0.01–5 µM), the lowest predicted effective
brain concentration would be 0.0006 ng/µg (resulting from
0.01 µM), which is far lower than the reported 0.02 ng/µg of
mCPP in rodent brain showing significant hypoactive behavior.
In rodents, chronic exposure of mCPP resulted in behavioral
tolerance (Ulrichsen et al., 1992; Fone et al., 1998). Therefore,
in zebrafish larvae, irrespective of the brain concentrations, a
hypoactive behavioral tolerance might explain the lack of a
concentration-dependent effect, although tolerance is generally
expected upon chronic exposure conditions. Therefore, future
research should address whether zebrafish are capable of
developing tolerance also after much shorter exposure durations.
Another potential explanation is that high accumulation of
mCPP in the brain or eyes may have led to disturbances
in the brain or visual signaling, contributing to hypoactive
behavior.
CONCLUSION
Our data shows that, similar to mammals, melanin acts as a
binding site for accumulation of basic drugs also in zebrafish
larvae. The affinity of chemicals to melanin differs depending
on the chemicals’ structure, as seen for mCPP and cocaine.
These differences in interactions with melanin contribute to the
differences in uptake, binding and elimination of basic drugs
from zebrafish larvae, thus influencing the toxicokinetics to a
great extent. Given the high uptake of mCPP in zebrafish larvae,
we suggest the presence of active transport mechanisms operating
at this stage. Finally, zebrafish larval responses to mCPP are
both concordant and discordant compared to mammals. Despite
the differences in effective tissue levels in zebrafish larvae and
rodents, we observed similar behavioral responses. While this
may suggest that zebrafish larvae could be a useful model
to study serotonin-targeting drugs, further investigations with
other serotonin-targeting drugs are needed to support this
proposal.
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